First Development Resources plc (FDR) has commenced its Phase I Diamond Drilling Programme at the Wallal Project in Western Australia, marking a key step forward in its exploration strategy.
First Development Resources plc (FDR) has commenced its Phase I Diamond Drilling Programme at the Wallal Project in Western Australia, marking a key step forward in its exploration strategy.
BBC: Spurs ‘not for sale’ as owner rejects buyout interest
Citywire: The FCA has warned of scam emails sent by fraudsters posing to be the regulator to dupe people into sending money. The regulator revealed it has received almost 5,000 fake
First Development Resources plc (AIM: FDR) a UK based, Australia focused exploration company with mineral interests in Western Australia and the Northern Territory, is pleased to provide an update in
(Alliance News) – Stock prices in London opened lower on Wednesday, following hotter-than-expected consumer inflation data which supported expectations that Bank of England will not cut rates in November. The consumer
First Development Resources plc (FDR) announced the completion of site access and the drilling platform for its Phase I diamond drilling program at the Wallal Project in Western Australia’s Paterson
The AIM All-Share barely moved week-on-week, closing at 761.15, as it succumbed to the usual mid-August slowdown.
The FTSE 100 closed down 64 points on Friday, or 0.7%, at 9,068, marking its lowest finish since 23 July and pulling back from record highs set just a day
First Development Resources plc (AIM: FDR) a UK based, Australian focused exploration company with mineral interests in Western Australia and Australia’s Northern Territory, is pleased to announce that it has
Power Metal Resources PLC (AIM: POW), the London-listed exploration company with a global project portfolio, is pleased to announce that First Development Resources PLC (“FDR”) will commence trading on AIM
The Times: FTSE 100 drugs giant AstraZeneca (AZN) has posted better-than-expected interim results boosted by strong sales of key cancer, heart and kidney disease drugs. Operating profit rose 23 per cent to $7.18
The AIM All-Share Index, often seen as a barometer for UK small-cap stocks, ended the session broadly flat, adding just 2 points to close at 772.05. The pause comes after several weeks